JAX extends research on cancer and lung disease

The Jackson Laboratory (JAX) reports that it has signed a research agreement for up to $4.2 million with Sanofi to identify new targets to treat triple-negative breast cancer and ovarian carcinoma … more

Separately, with an $11M grant, a major new research center led by JAX Professor Karolina Palucka, M.D., Ph.D., will explore the mechanisms of antiviral lung immune function and the role of the lung microbiome. The center will also investigate changes brought about by two diseases: adult lung cancer and childhood asthma … more